Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Ferrari

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|December 23, 2003
Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone diseasePaolo Ferrari
Nephrology (Carlton, Vic.)|February 14, 2007
Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney diseasePaolo Ferrari
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Early kidney allograft loss-Is there scope for improvement?Paolo Ferrari
Kidney International|October 1, 2009
Licorice: a sweet alternative to prevent hyperkalemia in dialysis patients?Paolo Ferrari
Current Hypertension Reports|January 16, 2002
Genetics of the mineralocorticoid system in primary hypertensionPaolo Ferrari
Transplant International : Official Journal of the European Society for Organ Transplantation|February 27, 2013
Response to Kute: 'facilitators to national kidney paired donation program'Paolo Ferrari
Biochimica Et Biophysica Acta|November 14, 2009
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertensionPaolo Ferrari
Journal of Hypertension|June 15, 2007
The challenge of renal cystic disease and its association with hypertension, age and abnormal potassium handlingPaolo Ferrari
Transplantation|February 6, 2019
Utilization of Deceased Donor Kidneys to Initiate Living Donor Chains: Practical, Ethical, and Logistical IssuesPaolo Ferrari
Circulation|May 1, 2002
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxidePaolo Ferrari
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Best Practice & Research. Clinical Endocrinology & Metabolism|December 23, 2003
Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone diseasePaolo Ferrari
Nephrology (Carlton, Vic.)|February 14, 2007
Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney diseasePaolo Ferrari
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Early kidney allograft loss-Is there scope for improvement?Paolo Ferrari
Kidney International|October 1, 2009
Licorice: a sweet alternative to prevent hyperkalemia in dialysis patients?Paolo Ferrari
Current Hypertension Reports|January 16, 2002
Genetics of the mineralocorticoid system in primary hypertensionPaolo Ferrari
Transplant International : Official Journal of the European Society for Organ Transplantation|February 27, 2013
Response to Kute: 'facilitators to national kidney paired donation program'Paolo Ferrari
Biochimica Et Biophysica Acta|November 14, 2009
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertensionPaolo Ferrari
Journal of Hypertension|June 15, 2007
The challenge of renal cystic disease and its association with hypertension, age and abnormal potassium handlingPaolo Ferrari
Transplantation|February 6, 2019
Utilization of Deceased Donor Kidneys to Initiate Living Donor Chains: Practical, Ethical, and Logistical IssuesPaolo Ferrari
Circulation|May 1, 2002
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxidePaolo Ferrari
Pageof 20